the aid library

LIST OPTIONS

Lista de medicamentos esenciales para el manejo de pacientes que ingresan a unidades de cuidados intensivos con sospecha o diagnóstico confirmado de COVID 19. Tercera versión, 1 de febrero del 2022
recommended

Organización Mundial de la Salud OMS OPS (2022) C_WHO

List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022

Download (6265)

View PDF (5149)

Leprosy For Medical Practitioners and Paramedical Workers
recommended

Yawalker, S. (2009) C1

Download (1398)

View PDF (3429)

Preventive chemotherapy in human helminthiasis : coordinated use of anthelminthic drugs in control

World Health Organization (2006) C_WHO

Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers

Download (1293)

View PDF (2508)

A Handbook for Auxiliary Nurse Midwives Lady Health Visitors & Staff Nurses

Maternal Health Division Ministry of Health and Family Welfare Government of India Maternal Health Division Ministry of Health and Family Welfare Government of India (2010) C1

Download (1015)

View PDF (1380)

Youth-Friendly Services - A Manual for Service Providers

EngenderHealth (2002)

All young people, including those with special needs and from the most vulnerable groups, have the right to quality health care services. Unfortunately, this right is not a reality, particularly in the case of sexual and reproductive health services. Many youth in need of sexual and reproductive hea... more

External Link

Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study

Velho Barreto de Araújo, T.; et al. (2016)

THELANCETID-D-16-00800 S1473-3099(16)30318-8

Download (332)

View PDF (1451)

Tuberculosis control in complex emergencies

World Health Organization Eastern Mediterranean (2015) C_WHO

Download (397)

View PDF (916)

National Strategic Plan for HIV/AIDS and STI 2017 – 2024: “Paving Way for an AIDS Free India”

Government of India, Ministry of Health and Family Welfare, National AIDS Control Organisation (NACO) (2017) C1

The National Strategic Plan for HIV/AIDS and STIs 2017-2024 spells out the objectives and targets that we have jointly committed to achieve. The plan describes the strategies and activities that will need to be implemented on the ground across India's 36 States and Union Territories with the help of... more

Download (347)

View PDF (320)

National Guidelines in the Management of Retinoblastoma

Indian Council of Medical Research (ICMR) (2010) C1

These Guidelines are intended to provide knowledge to the treating ophthalmologists, pediatricians, ocular oncologists, pediatric oncologists, and general physicians to arrive at an early diagnosis of retinoblastoma in the settings of district hospital, in private clinics and hospitals. The guidelin... more

Download (140)

View PDF (209)

The mental health of children facing collective adversity poverty, homelessness, war and displacement

L. Pacione; T. Measham; R.l Kronick; et al. IACAPAP (2012) C2

Miscellaneous Chapter J.4

Download (107)

View PDF (152)

резервные препараты под микроскопом - противотуберкулезные средства: источники и цены

Médecins Sans Frontières (MSF) (2016) C1

В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб�... more

Tuberculosis. ¿Es la pandemia ignorada?

Barba, E.; and J. Roberto (2020) C1

Rev Mex Patol Clin Med Lab 2020; 67 (2): 93-112: La tuberculosis (TB) es en la actualidad la patología de tipo infeccioso que causa mayor número de muertes alrededor del mundo cada año. La percepción acerca de esta entidad ha cambiado a lo largo del tiempo, ya que se consideraba que se relaciona... more

Definição e categorização do momento da transmissão vertical do SARS-CoV-2 Informe científico 8 de fevereiro de 2021

Organização Mundial da Saúde (OMS) OPAS, OMS (2021) C_WHO

Definition and categorization of the time of vertical transmission of SARS-CoV-2 Scientific report 8 February 2021

External Link

Challenges in management and prevention of ischemic heart disease in low socioeconomic status people in LLMICs

Gupta, R.; Yusuf, S. BMC Medicine (2019) CC

Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (... more

External Link

Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study

GBD 2019 Blindness and Vision Impairment Collaborator The Lancet (2020) CC

External Link

Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019

GBD 2019 Tuberculosis Collaborators (2022) CC

Lancet Infect Dis 2022; 22: 222–4

External Link

Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward

Minja, N.W.; Nakagaayi, D.; Aliku, T. et al. Frontiers in Cardiovascular Medicine (2022) CC

In 2015, the United Nations set important targets to reduce premature cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately bears the brunt of CVD burden and has one of the highest risks of dying from non-communicable diseases (NCDs) worldwide. There is currently an epide...miological transition on the continent, where NCDs is projected to outpace communicable diseases within the current decade. Unchecked increases in CVD risk factors have contributed to the growing burden of three major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age standardized disability-adjusted life years (DALYs) due to hypertensive heart disease (HHD) were recorded in Africa. The contributory causes of heart failure are changing—whilst HHD and cardiomyopathies still dominate, ischemic heart disease is rapidly becoming a significant contributor, whilst rheumatic heart disease (RHD) has shown a gradual decline. In a continent where health systems are traditionally geared toward addressing communicable diseases, several gaps exist to adequately meet the growing demand imposed by CVDs. Among these, high-quality research to inform interventions, underfunded health systems with high out-of-pocket costs, limited accessibility and affordability of essential medicines, CVD preventive services, and skill shortages. Overall, the African continent progress toward a third reduction in premature mortality come 2030 is lagging behind. More can be done in the arena of effective policy implementation for risk factor reduction and CVD prevention, increasing health financing and focusing on strengthening primary health care services for prevention and treatment of CVDs, whilst ensuring availability and affordability of quality medicines. Further, investing in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on interventions. This review summarizes the current CVD burden, important gaps in cardiovascular medicine in Africa, and further highlights priority areas where efforts could be intensified in the next decade with potential to improve the current rate of progress toward achieving a 33% reduction in CVD mortality. more